| Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use JD Brown, AG Winterstein Journal of clinical medicine 8 (7), 989, 2019 | 330 | 2019 |
| Predictive validity of the beers and screening tool of older persons’ potentially inappropriate prescriptions (STOPP) criteria to detect adverse drug events, hospitalizations … JD Brown, LC Hutchison, C Li, JT Painter, BC Martin Journal of the American Geriatrics Society 64 (1), 22-30, 2016 | 137 | 2016 |
| Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment JD Brown, AJ Goodin, JC Talbert The Journal of rural health 34 (1), 6-13, 2018 | 111 | 2018 |
| Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial … M Proietti, GYH Lip, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 23 (2), 174-183, 2021 | 100 | 2021 |
| Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillation JD Brown, AR Shewale, JC Talbert Journal of managed care & specialty pharmacy 22 (11), 1319-1329, 2016 | 98 | 2016 |
| Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism … GK Dawwas, J Brown, E Dietrich, H Park The Lancet Haematology 6 (1), e20-e28, 2019 | 93 | 2019 |
| The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States JD Brown, J Harnett, R Chambers, R Sato BMC geriatrics 18, 1-11, 2018 | 89 | 2018 |
| Risk stratification for bleeding complications in patients with venous thromboembolism: application of the HAS‐BLED bleeding score during the first 6 months of anticoagulant … JD Brown, AJ Goodin, GYH Lip, VR Adams Journal of the American Heart Association 7 (6), e007901, 2018 | 88 | 2018 |
| Increased prevalence of mitral valve prolapse in patients with migraine JD Spence, DG Wong, LJ Melendez, PM Nichol, JD Brown Canadian Medical Association Journal 131 (12), 1457, 1984 | 81 | 1984 |
| Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine A Sarayani, B Cicali, CH Henriksen, JD Brown Research in Social and Administrative Pharmacy 17 (2), 483-486, 2021 | 76 | 2021 |
| Effect of fluid bolus administration on cardiovascular collapse among critically ill patients undergoing tracheal intubation: a randomized clinical trial DW Russell, JD Casey, KW Gibbs, S Ghamande, JM Dargin, ... Jama 328 (3), 270-279, 2022 | 74 | 2022 |
| Machine learning in drug discovery and development part 1: A primer A Talevi, JF Morales, G Hather, JT Podichetty, S Kim, PC Bloomingdale, ... CPT: pharmacometrics & systems pharmacology 9 (3), 129-142, 2020 | 71 | 2020 |
| Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort JD Brown, D Raissi, Q Han, VR Adams, JC Talbert Journal of the American Heart Association 6 (9), e006708, 2017 | 71 | 2017 |
| Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 data JD Brown, AR Shewale, JC Talbert Journal of managed care & specialty pharmacy 23 (9), 958-967, 2017 | 63 | 2017 |
| Potential adverse drug events with tetrahydrocannabinol (THC) due to drug–drug interactions JD Brown Journal of clinical medicine 9 (4), 919, 2020 | 61 | 2020 |
| Reliability and validity of the short-form 12 item version 2 (SF− 12v2) health-related quality of life survey and disutilities associated with relevant conditions in the US … CH Shah, JD Brown Journal of clinical medicine 9 (3), 661, 2020 | 61 | 2020 |
| Characteristics of older adults who were early adopters of medical cannabis in the Florida Medical Marijuana Use Registry JD Brown, B Costales, S van Boemmel-Wegmann, AJ Goodin, R Segal, ... Journal of clinical medicine 9 (4), 1166, 2020 | 59 | 2020 |
| Association of oral anticoagulants and verapamil or diltiazem with adverse bleeding events in patients with nonvalvular atrial fibrillation and normal kidney function P Pham, S Schmidt, L Lesko, GYH Lip, JD Brown JAMA network open 3 (4), e203593-e203593, 2020 | 59 | 2020 |
| Risk of opioid overdose associated with concomitant use of opioids and skeletal muscle relaxants: a population‐based cohort study Y Li, C Delcher, YJJ Wei, GM Reisfield, JD Brown, P Tighe, ... Clinical Pharmacology & Therapeutics 108 (1), 81-89, 2020 | 57 | 2020 |
| Development of obesity competencies for medical education: a report from the Obesity Medicine Education Collaborative RF Kushner, DB Horn, WS Butsch, JD Brown, K Duncan, CS Fugate, ... Obesity 27 (7), 1063-1067, 2019 | 57 | 2019 |
Amie GoodinAssistant Professor, University of Florida. Pharmaceutical Outcomes & Policy.Email được xác minh tại ufl.edu